Creatine kinase and fibrillation potentials in patients with late sequelae of polio.
The incidence of an elevated creatine kinase (CK) in a group of polio patients with delayed weakness (15/29) did not differ from polio patients without delayed weakness (9/31) or others with amyotrophic lateral sclerosis (ALS; 10/21). Mean CK in polio patients without delayed weakness (151 IU/L) was lower than the CK in those with delayed weakness (270 IU/L) or ALS (224 IU/L) (P less than 0.05). An elevated CK in polio patients with delayed weakness did not correlate with new or residual weakness. These findings suggest that muscle overuse is either not important or inadequately measured by CK. Widely distributed fibrillations were associated with an elevated CK for all polio patients combined (P less than 0.01). Fibrillations occurred in more muscles of polio patients with delayed weakness (P less than 0.01) and implies that late denervation may play a role in the development of new weakness in some polio patients.
Nelson
K R
KR
Department of Neurology, University of Kentucky, Lexington 40536-0084.
D000200:Action Potentials; D000328:Adult; D003402:Creatine Kinase / Q000097:blood* / Q000592:standards; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000201:enzymology* / Q000473:pathology; D009133:Muscular Atrophy / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D011051:Poliomyelitis / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology
D003402:Creatine Kinase